texas

Showing 7 posts of 7 posts found.

US moving remdesivir supplies to COVID-19 hotspots

July 6, 2020
Sales and Marketing Arizona, COVID, states, texas

The US government is sending significant remdesivir supplies to states that are being hit hardest by the coronavirus. Florida, Arizona …

Scientists develop treatment for all strains of Ebola

January 10, 2019
Research and Development Ebola, primates, research UTMB, texas, zmapp

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …

Azacitidine and nivolumab combo proves successful in phase II trial

November 13, 2018
Manufacturing and Production Cancer, leukaemia, opdivo, pharma, texas

A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with relapsed or …

Nobel Prize awarded to immuno-oncology innovators

October 2, 2018
Manufacturing and Production Cancer, Nobel Prize, immunotherapy, kyoto, oncology, texas

The Nobel Prize for physiology or medicine has been awarded to both Professor James P Allison and Tasuku Honjo for …

Texas launches lawsuit against FDA over lethal drug shipment

January 4, 2017
Medical Communications, Research and Development FDA, texas

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …

Pfizer sues Texas agency over leak of drug prices

November 21, 2016
Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas

Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …

Allergan breaks ground on $200 million expansion at Texas site

April 26, 2016
Manufacturing and Production Allergan, doubling, expansion, eye care, facility, investment, manufacturing, size, texas, waco

Allergan (NYSE: AGN) has broken ground on a $200 million expansion at its manufacturing facility in Waco, Texas. The expansion …

The Gateway to Local Adoption Series

Latest content